Description
About ACE-031
ACE-031 is a recombinant fusion protein comprising the extracellular domain of activin receptor type IIA (ActRIIA) fused to a human IgG1 Fc region. It acts as a ligand trap for activin, myostatin, and related TGF-β superfamily members. ACE-031 has an estimated molecular weight of approximately 60,000 g/mol as a homodimeric Fc fusion protein.
ACE-031 is used in preclinical research investigating ActRIIA ligand biology and muscle-related signalling pathways. It is a valuable research tool for studying the role of ActRIIA pathway components in muscle physiology.
ACE-031 Peptide Specifications
- Product Name: ACE-031 1mg
- Molecular Formula: ActRIIA-Fc fusion (recombinant)
- Molecular Weight: ~60,000 g/mol
- Purity: ≥98% — HPLC and MS-UPLC verified
- Sequence: ActRIIA extracellular domain fused to human IgG1 Fc
- Form: Lyophilised solid
- Certification: cGMP and ISO9001 compliant manufacturing
Storage and Reconstitution
ACE-031 1mg is supplied in lyophilised solid form for optimal stability in research settings. Vials are stored in a monitored, temperature-controlled environment to maintain integrity prior to dispatch.
For reconstitution and storage guidance, refer to our peptide reconstitution instructions and peptide storage instructions. We recommend our Bacteriostatic Mixing Solution for reconstitution.
All PeptidesUK products are sold strictly for in vitro research purposes only and are not intended for human consumption.